Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Eli Lilly Corp. buy Traumtanz

Eli Lilly Corp.
Start price
€99.33
19.12.18 / 50%
Target price
€126.28
07.01.19
Performance (%)
2.04%
End price
€101.36
07.01.19
Summary
This prediction ended on 07.01.19 with a price of €101.36. With a performance of 2.04%, the BUY prediction by Traumtanz for Eli Lilly Corp. closed with a slight gain. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eli Lilly Corp. 0.087% 0.087% 91.291% 357.571%
iShares Core DAX® 0.961% -2.210% 12.839% 17.154%
iShares Nasdaq 100 2.626% -1.918% 38.498% 45.463%
iShares Nikkei 225® 0.217% -7.216% 19.425% 5.076%
iShares S&P 500 1.540% -1.858% 27.801% 42.583%

According to Traumtanz what are the pros and cons of Eli Lilly Corp. for the foreseeable future?

Pros
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Good culture
Innovative
Some uniques
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons

Comments by Traumtanz for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 2.04%
Target price 126.280
Change
Ends at 07.01.19

Traumtanz stimmt der Buy-Einschätzung von gerihouse zu Eli Lilly zu.

Traumtanz stimmt am 19.12.2018 der Buy-Einschätzung von gerihouse zu.
Überschrift: Dividenden Aristokrat

Traumtanz 
0
Report Share
19.12.18
Prediction Buy
Perf. (%) 2.04%
Target price 126.280
Change
Ends at 07.01.19

(Stop Loss Kurs erreicht)

Traumtanz 
0
Report Share
07.01.19

Stopped prediction by Traumtanz for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.12.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€568.50
11.10.23
€558.00
11.10.24
-7.48%
14.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
11.10.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
19.09.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
15.09.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
17.08.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
05.05.23
€395.00
05.05.24
3.52%
12.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
05.05.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.80
29.10.22
€400.00
29.10.23
6.95%
05.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
29.10.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€338.70
07.10.22
€350.00
07.10.23
7.12%
29.10.22

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
07.10.22 80%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€125.04
16.10.20
€120.00
04.11.21
4.56%
09.12.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
16.10.20 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.00
14.10.20
€120.00
16.10.20
-0.76%
16.10.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.10.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€134.00
07.04.20
€175.00
10.06.20
-0.91%
10.06.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
07.04.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€106.50
24.01.19
€126.28
28.01.19
-3.53%
28.01.19

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
05.08.19 50%